| Characteristic | Net sales in million U.S. dollars |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
February 2025
Worldwide
2009 to 2024
Data prior to 2023 have been taken from previous annual reports.
* Fiscal years 2009, 2010, 2012 and 2013 contained 52 weeks. On November 14, 2013, the Board of Directors approved a resolution to change MCBC's fiscal year from a 52/53 week fiscal year to a calendar year. As such, the 2013 fiscal year was extended from December 28, 2013 to December 31, 2013, which subsequent fiscal years beginning on January 1 and ending on December 31 of each year.
** Fiscal year 2011 contained 53 weeks.
*** Includes MillerCoors' results of operations on a consolidated basis for the post-Acquisition period October 11, 2016 , through December 31, 2016 , as well as the assets acquired and related debt issued in connection with the Acquisition. Prior to October 11, 2016 , MCBC’s 42% share of MillerCoors' results of operations were reported as equity income in MillerCoors in the consolidated statements of operations and 42% share of MillerCoors' net assets were reported as Investment in MillerCoors in the consolidated balance sheets. Also included in net income from continuing operations attributable to MCBC is a net special items gain of approximately $3.0 billion related to the fair value remeasurement of our pre-existing 42% interest in MillerCoors over its carrying value, as well as the reclassification of the loss related to MCBC's historical AOCI on 42% interest in MillerCoors.









